AI-powered atlas reveals how tertiary lymphoid structures predict cancer treatment outcomes
Researchers at MD Anderson Cancer Center developed the first comprehensive spatial atlas of tertiary lymphoid structures across 12 cancer types, using AI to analyze over 25,000 immune structures. The study shows that TLS maturation state, spatial location, and composition provide critical insights into cancer prognosis and treatment response, outperforming conventional biomarker measures.